You are here: Industry Insights > GSK

News List

GSK, Bayer top global ranking for online messaging fiercepharma
February 09, 2018
GlaxoSmithKline is the first pharma in almost a decade to top Bowen Craggs & Co.'s online excellence ranking.
GlaxoSmithKline notifies SEC, DOJ of new questions in China bribery probe fiercepharma
February 09, 2018
The U.K. drugmaker has now been asked for new info from fraud investigators in its home country.
GSK reported 3 percent hike in 2017 sales pharmatimes
February 09, 2018
GSK has reported a sales rise of 3 percent at constant exchange rates (CER*) for 2017, after growth was recorded across all of its three global businesses.
Gardasil's growth led Merck's vaccine sales of $6.5B in 2017 as Zostavax struggles fiercepharma
February 07, 2018
Merck's vaccine business kept churning in 2017, generating sales of $6.5 billion and growing by 4.8% over the prior year.
Exagen collaborates with GSK for lupus treatment biospectrumasia
January 30, 2018
Both Exagen and GSK share a common goal to help SLE patients shorten the time to their diagnosis, which is nearly six years on average, and to facilitate improved patient health outcomes.
GSK forced to pay back £1.5m to Scottish Government after recent job cuts pharmafile
December 21, 2017
British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure to keep its promises of a planned expansion.
GSK commits to multi-million investment in UK life sciences sector deal pharmafile
December 07, 2017
In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new drug targets.
Two big pharma companies accused of false marketing pharmafile
December 07, 2017
Novartis and GSK have been taken to court by the Australian Competition and Consumer Commission (ACCC) over allegations of falsely marketing their Osteo Gel pain relief product.
GSK submits bold US application for tafenoquine, targeting malaria pharmaasia
December 07, 2017
Bold GSK attempt is for the first new medicine targeting P.vivax malaria in 60 years. Tafenoquine is not approved for use anywhere in the world.
GSK submits landmark IMPACT data to US regulatory authority to support expanded label for Trelegy El worldpharmanews
November 24, 2017
Approval of this sNDA means FF/UMEC/VI could be used by physicians to treat a wider population of patients with COPD who are at risk of an exacerbation and require triple therapy.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page